SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-17-017472
Filing Date
2017-06-28
Accepted
2017-06-28 19:52:16
Documents
1
Period of Report
2017-06-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2894
  Complete submission text file 0000899243-17-017472.txt   4435
Mailing Address 281 ALBANY STREET CAMBRIDGE MA 02139
Business Address 281 ALBANY STREET CAMBRIDGE MA 02139 617-995-0900
AILERON THERAPEUTICS INC (Issuer) CIK: 0001420565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address OMC CHAMBERS, WICKHAMS CAY 1 ROAD TOWN, TORTOLA D8 00000
Business Address OMC CHAMBERS, WICKHAMS CAY 1 ROAD TOWN, TORTOLA D8 00000 505-894-93587
Sigma Emerging Markets Ltd. (Reporting) CIK: 0001709926 (see all company filings)

State of Incorp.: D8 | Fiscal Year End: 1217
Type: 3 | Act: 34 | File No.: 001-38130 | Film No.: 17936546